A Novel Pre-treatment Model Predicting Risk of Developing Refractoriness to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma

Conclusions: This study presents a pre-treatment model to identify patients with high risks of refractoriness after transarterial chemoembolization and shed light on clinical decision making.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Keshu Hu, Shenxin Lu, Miao Li, Feng Zhang, Bei Tang, Jia Yuan, Yan Shan, Pengju Xu, Rongxin Chen, Zhenggang Ren, Xin Yin Tags: Research Paper Source Type: research